In December of 2022, Candice Coleman embarked on a journey of self-discovery that would profoundly alter the course of her life. While inherently in tune with her body, she was startled to discover a pea-sized lump in her right breast, an unprecedented revelation that prompted a cascade of emotions. Initially, Candice attributed the lump to hormonal fluctuations, only to realize that her menstrual cycle, expected that week, had taken an unexpected turn. It was this pivotal moment that marked the beginning of her unique and inspiring story. 

Candice’s recent conversation with us illuminated her resilience and unwavering openness about her experiences. She graciously shared her personal journey, emphasizing the vital importance of advocacy and self-awareness in the face of life-altering challenges. Despite the hurdles, Candice’s strength shines through, making her not only a survivor but a potent advocate for others grappling with similar circumstances. 

Candice passionately emphasizes the pivotal role of clinical trials in cancer treatment. Her journey took an inspiring turn when she encountered an individual who not only shared similar health struggles but had also undergone a clinical trial tailored for a triple-negative breast cancer diagnosis—mirroring Candice’s own experience. The serendipitous connection with a young Black women provided Candice with a unique opportunity to establish a profound and personal bond. Grateful for the chance to express her appreciation, Candice conveyed that her effective treatment plan owed its success to the groundbreaking clinical trial undertaken by her newfound acquaintance. This encounter underscored the significance of representation and inclusivity in medical research, offering a poignant testament to the impact of shared experiences within the broader context of healthcare advancements. 

The glaring absence of clinical trial opportunities for Black women with breast cancer underscores a critical disparity in healthcare. This omission denies these women the chance to access cutting-edge treatments, hindering progress in understanding how breast cancer manifests across diverse populations. 

As Candice aligns her journey with Bexa Equity Alliance, her narrative unfolds as a beacon of hope and inspiration. Her commitment to advocacy and self-empowerment stands as a testament to the transformative power of sharing one’s story. However, amid these inspiring tales, a stark reality persists — clinical trials, critical for advancing breast cancer treatments, often neglect Black women. 

Candice’s story sheds light not only on her personal triumphs but also on the urgent need for inclusivity in clinical trials. By addressing these disparities, we can pave the way for a future where all women, regardless of ethnicity, have equitable access to the latest advancements in breast cancer research and treatment.